Evidence map›Paper›PMID 31470675›Full record

ArticleGenes2019

Two Years of Viral Metagenomics in a Tertiary Diagnostics Unit: Evaluation of the First 105 Cases.

Verena Kufner, Andreas Plate, Stefan Schmutz, Dominique L Braun, Huldrych F Günthard, Riccarda Capaul, Andrea Zbinden, Nicolas J Mueller, Alexandra Trkola, Michael Huber

Abstract read
In one paragraph

Article in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Fulminant echovirus 11 hepatitis in male non-identical twins in northern Italy, April 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  8. Review
  9. Article
  10. Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samples.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Verena KufnerInstitute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Andreas PlateDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Stefan SchmutzInstitute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Dominique L BraunInstitute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Huldrych F GünthardInstitute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Riccarda CapaulInstitute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Andrea ZbindenInstitute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Nicolas J MuellerDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland. nicolas.mueller@usz.ch.
Alexandra TrkolaInstitute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland. trkola.alexandra@virology.uzh.ch.
Michael HuberInstitute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland. huber.michael@virology.uzh.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metagenomic next-generation sequencing (mNGS) can capture the full spectrum of viral pathogens in a specimen and has the potential to become an all-in-one solution for virus diagnostics. To date, clinical application is still in an early phase and limitations remain. Here, we evaluated the impact of viral mNGS for cases analyzed over two years in a tertiary diagnostics unit. High throughput mNGS was performed upon request by the treating clinician in cases where the etiology of infection remained unknown or the initial differential diagnosis was very broad. The results were compared to conventional routine testing regarding outcome and workload. In total, 163 specimens from 105 patients were sequenced. The main sample types were cerebrospinal fluid (34%), blood (33%) and throat swabs (10%). In the majority of the cases, viral encephalitis/meningitis or respiratory infection was suspected. In parallel, conventional virus diagnostic tests were performed (mean 18.5 individually probed targets/patients). mNGS detected viruses in 34 cases (32%). While often confirmatory, in multiple cases, the identified viruses were not included in the selected routine diagnostic tests. Two years of mNGS in a tertiary diagnostics unit demonstrated the advantages of a single, untargeted approach for comprehensive, rapid and efficient virus diagnostics, confirming the utility of mNGS in complementing current routine tests.

Indexed as

MetagenomeBloodCerebrospinal FluidGenome, ViralHumansMetagenomicsMolecular Diagnostic TechniquesMouth MucosaSequence Analysis, DNATertiary Care CentersVirus Diseasesclinical impactdiagnosticsmetagenomic sequencingvirusvirus infection

Identifiers

PMID31470675
PMCPMC6770117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.